Elli Papaemmanuil PhD

Dr. Papaemmanuil is an Assistant Attending Computational Oncologist in the Department of Epidemiology and Biostatistics and an Affiliate Member of the Cancer Genetics and Biology Programme. She is affiliated with the Marie-Josée and Henry R. Kravis Center for Molecular Oncology, and is the Associate Director for the Center of Hematological Malignancies. Dr. Papaemmanuil was trained in Human Molecular Genetics at the University of Glasgow, and completed PhD studies in Population Genetics and Epidemiology and conducted her postdoctoral research at the Cancer Genome Project at the Wellcome Trust Sanger Institute in Cambridge UK.

Dr Papaemmanuil is a certified computer systems and operations development analyst by the British Society of Computing. Dr Papaemmanuil’s research is focused on developing comprehensive laboratory and novel analytical methodologies to study the role of acquired mutations in cancer, and how these define clinical phenotype and determine therapeutic response. Dr Papaemmanuil works with large and well-annotated clinical trial cohorts to study the diagnostic, prognostic and predictive value of genomic variation and how this knowledge can guide development of future clinical protocols.